Hong Kong has no intention and sees no need to change the system that pegs the city's currency in a tight band to the U.S.

Behind Girma on the depth chart, San Diego has limited options at the centerback position. Kennedy Wesley impressed as a rookie and Kristen McNabb can fill in the center of defense when necessary. But ...

We recently published a list of 15 AI Stocks That Skyrocketed in Q4. In this article, we are going to take a look at where ...

Barclays raised its price target on Ulta Beauty Inc (NASDAQ:ULTA) to $445 from $410 on stronger-than-expected preliminary ...

On Wednesday, Barclays PLC (BCS) stock saw a decline, ending the day at $13.19 which represents a decrease of $-0.06 or -0.45% from the prior close of $13.25. The stock opened at $13.01 and touched a ...

Over the past two weeks, few teams have been as hot as the Detroit Pistons. Following another victory, their star player gave ...

The S&P 500 Index (SPX) generated “unusually strong” return during the first three quarters of 2024 – compared to the ...

Investment firm Barclays laid out its thoughts for the technology space in 2025 in a research note on Thursday. Read for more ...

Amazon’s satellite broadband initiative, Project Kuiper, shows huge potential. Find out why AMZN stock could thrive with a ...

Barclays analyst Peter Lawson maintained a Hold rating on Blueprint Medicines (BPMC – Research Report) today and set a price target of $105.00.

Barclays PLC lifted its holdings in shares of Regulus Therapeutics Inc. (NASDAQ:RGLS – Free Report) by 285.2% during the 3rd quarter, Holdings Channel reports. The firm owned 84,477 shares of the ...

In a report released today, Seth Sigman from Barclays maintained a Hold rating on Five Below (FIVE – Research Report), with a price target of ...